MedPath
HSA Approval

TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL

SIN15588P

TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL

TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL

December 3, 2018

ACCORD HEALTHCARE PRIVATE LIMITED

ACCORD HEALTHCARE PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantACCORD HEALTHCARE PRIVATE LIMITED
Licence HolderACCORD HEALTHCARE PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

L01CD02

docetaxel

Manufacturer Information

ACCORD HEALTHCARE PRIVATE LIMITED

INTAS PHARMACEUTICALS LIMITED

Active Ingredients

DOCETAXEL ANHYDROUS

20 mg / mL

Docetaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL - HSA Approval | MedPath